chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Contusion, Immediate post-injection reaction
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (route, lot number and expiration date were not provided). No concomitant medication was reported. Immediately after receiving the injection the patient developed a contusion (described as "sort of a big bruise"). The outcome of the contusion was unknown. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 02-AUG-2013, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # H015630 and expiry date: 21-FEB-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 23-OCT-2014, the patient was vaccinated with the first dose of ZOSTAVAX and then was inadvertently administered a second dose of ZOSTAVAX injection (strength, dose, route of administration, lot# and expiry date unspecified for both) on 22-JAN-2015. No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report has been received from a nurse practitioner refers to a female patient of unknown age. Medical history and current condition of the patient were not reported. The patient received her first dose of GARDASIL (lot#, expiry date unspecified), 0.5 ml, intramuscularly on 27-FEB-2012 and her second dose of GARDASIL on 15-JAN-2015 (Inappropriate schedule of vaccine administered). No adverse effect reported. The third dose had not been administered. No product quality complaint (PQC) involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On an unknown date, an unspecified number of patients were vaccinated with doses of M-M-R II, (strength, dose, frequency, route, anatomical location, lot number and expiration date were not provided), which were improperly stored (Incorrect product storage). No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 01-AUG-2013, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # H018796 and expiry date: 24-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Age: 1.99
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: 7am swelling with redness. No pain to palpation, mildly warm. Itchy x 2 days. Advised to ice, BENADRYL, and Hydrocortisone cream.
Sex: U
Vaccine: PPV
Symptoms: Interchange of vaccine products
Clinical narrative: Information has been received from a pharmacist refers to patients of unknown age and gender who were enrolled in a market research program. On an unknown date the reporter had seen or heard that the PNEUMOVAX was recommended as the second dose in a series and PREVNAR should be given first for patients. The outcome of event was unknown. Additional information is not expected as the reporter was not wiling to be contacted.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse refers to unknown number of patients of unknown age and gender. The nurse reported that on unspecified dates, an unknown number of unspecified patients were inadvertently administered PNEUMOVAX 23 (lot#, route and dose unknown) which had been improperly stored. No adverse effects reported. There was no concomitant medication and no pertinent medical history reported. The outcome and action taken were not provided. This is one of several reports from the same source. Additional information is not expected since reporter did not allow to follow up.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse refers to unknown number of patients of unknown age and gender. The nurse reported that on unspecified dates, an unknown number of unspecified patients were inadvertently administered ROTATEQ (lot#, route and dose unknown) which had been improperly stored. No adverse effects reported. There was no concomitant medication and no pertinent medical history reported. The outcome and action taken were not provided. This is one of several reports from the same source. Additional information is not expected since the reporter did not allow to follow up.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse refers to unknown number of patients of unknown age and gender. The nurse reported that on unspecified dates, an unknown number of unspecified patients were inadvertently administered GARDASIL (lot#, route and dose unknown) which had been improperly stored. No adverse effects reported. There was no concomitant medication and no pertinent medical history reported. The outcome and action taken were not provided. This is one of several reports from the same source. Additional information is not expected since the reporter did not allow to follow up.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 08-APR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J011828 and expiry date: 26-DEC-2014, reported as 16-DEC-2014) which was improperly stored. Primary reporter was reporting exclusion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 08-APR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J011828 and expiry date: 26-DEC-2014, reported as 16-DEC-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: M
Vaccine: PPV
Symptoms: Local reaction
Clinical narrative: Information has been received from a physician via Pfizer Inc. concerning a male patient of unknown age. Patient's current condition or medical history was not reported. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, dose, route not reported). Concomitant medications were not provided. The physician reported that the patient had local reaction to PNEUMOVAX 23 (date unspecified). The outcome of local reaction was not reported. The causality was unspecified. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a register nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. The register nurse informed that on 21-JAN-2015 the patient was vaccinated with VARIVAX (Merck), 0.5 ml, subcutaneous, once, (lot# and expiration date were not reported), that was improperly stored. No adverse events were reported. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Ophthalmic herpes zoster
Clinical narrative: Developed shingles lesions on face and under left eye lid on 1/8/2015.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 21-NOV-2013, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J004319 and expiry date: 17-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 17-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K01104 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 07-NOV-2013 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J000783, expiration date: 30-APR-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 31-JUL-2013 was vaccinated with a dose of ZOSTAVAX {strength, dose and route not reported, lot # H021459, expiration date: 30-APR-2013 (also reported as 03-APR-2014)}, that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 24-OCT-2013 was vaccinated with a dose of ZOSTAVAX {strength, dose and route not reported, lot # H021459, expiration date: 30-APR-2013 (also reported as 03-APR-2014)}, that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from registered nurse refers to unspecified patients of unknown ages and genders who on unknown date in January 2015 (reported as since 21-JAN-2015) were vaccinated with a doses of PEDVAXHIB, intramuscular (dose, lot # and expiration date were not reported) which underwent a supported temperature excursion. No adverse effects were reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 10-OCT-2013 was vaccinated with a dose of ZOSTAVAX {strength, dose and route not reported, lot # H021459, expiration date: 30-APR-2013 (also reported as 03-APR-2014}, that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Loss of consciousness, Tremor
Clinical narrative: Patient complained of dizziness, lightheadedness. Patient sat and said started to fade to black she said - passed out, shaking, lost consciousness, gave 1 EPIPEN. Patient regained consciousness called 911, pt went by ambulance to hospital.
Sex: M
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: This spontaneous report as received from a pharmacist, via a company representative, refers to a male patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (route, lot number and expiration date were not provided). No concomitant medication was reported. 2-3 months following vaccination (unspecified date) the patient developed a vesicular rash (described as: a zoster-like rash). The patient sought unspecified medical attention. The outcome of vesicular rash was reported as recovered on an unknown date. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from registered nurse refers to unspecified patients of unknown ages and genders who on unknown date in January 2015 (reported as since 21-JAN-2015) were vaccinated with a doses of GARDASIL, intramuscular (dose, lot# and expiration date were not reported) which underwent a supported temperature excursion. No adverse effects were reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 27-NOV-2013 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J008802, expiration date: 19-OCT-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reproter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 25-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 23-MAY-2013 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J000783, expiration date: 30-APR-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 07-MAY-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J008802, expiration date: 19-OCT-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 08-JAN-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J008802, expiration date: 19-OCT-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Induration, Joint range of motion decreased, Peripheral swelling, Skin infection, Skin mass
Clinical narrative: Swollen arm, shoulder, collar bone area with decreased range of motion. Hardened skin, warm-to-touch. Patient reports a "hard pad" 3-4 inches deep in skin that can be manipulated/moved. Antibiotics used for presumed skin infection.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin warm, Swelling
Clinical narrative: Swollen arm, shoulder, collar bone area with decreased range of motion. Hardened skin, warm-to-touch. Patient reports a "hard pad" 3-4 inches deep in skin that can be manipulated/moved. Antibiotics used for presumed skin infection.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthritis, Blood test normal, Bone scan abnormal, Computerised tomogram, Erythema
Clinical narrative: Swollen arm, shoulder, collar bone area with decreased range of motion. Hardened skin, warm-to-touch. Patient reports a "hard pad" 3-4 inches deep in skin that can be manipulated/moved. Antibiotics used for presumed skin infection.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Full blood count, Injection site erythema, Injection site swelling, Metabolic function test, Mobility decreased
Clinical narrative: Swollen arm, shoulder, collar bone area with decreased range of motion. Hardened skin, warm-to-touch. Patient reports a "hard pad" 3-4 inches deep in skin that can be manipulated/moved. Antibiotics used for presumed skin infection.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Nuclear magnetic resonance imaging abnormal, Peripheral swelling, Red blood cell sedimentation rate, Skin warm, X-ray
Clinical narrative: Swollen arm, shoulder, collar bone area with decreased range of motion. Hardened skin, warm-to-touch. Patient reports a "hard pad" 3-4 inches deep in skin that can be manipulated/moved. Antibiotics used for presumed skin infection.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 19-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 19-DEC-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 24-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 10-DEC-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 14-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 05-DEC-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 17-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 12-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 15-DEC-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 06-NOV-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 24-DEC-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # K003597, expiration date: 12-MAR-2015), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a healthcare worker (also reported as clinical manager) refers to a patient of unknown age and gender who on 06-MAY-2014 was vaccinated with a dose of ZOSTAVAX (strength, dose and route not reported, lot # J008802, expiration date: 19-OCT-2014), that had been improperly stored. The temperature during the excursion was unknown, as it was not monitored. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: FLUX, PNC, VARZOS
Symptoms: Pain, Pain in extremity
Clinical narrative: Case number PHHY2013US116664 is an initial spontaneous report received from consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 481000) web site on 15 Oct 2013. This case refers to 60-year-old female patient. Her medical history included penicillin allergy. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported so conservatively coded as Seasonal Influenza vaccine INN), ZOSTAVAX (batch number: not reported, other manufacturer) 0.65 subcutaneously and PREVNAR (batch number: not reported, other manufacturer) on 18 Sep 2012. On 18 Sep 2012, after her vaccinations, the patient began to feel achy all over from her hands to her legs and arms. She did not seek medical attention. Treatment medication included ADVIL. The event outcome was recovering. The seriousness and causality of the event was not reported.
Age: 54.0
Sex: F
Vaccine: FLUX
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Case number PHHY2013US001375, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 474040) website on 02 JAN 2013. The case refers to a 54-year-female patient. Her medical history and concomitant medication were not reported. She was vaccinated with flu vaccine (manufacturer and batch number unknown) on an unspecified date (last year). On an unspecified date, after vaccination, she experienced vaccination site swelling and pain. The outcome , seriousness and causality of the events were not reported. Further, she was also vaccinated with FLUVIRIN 2012/2013 (batch number: 1205201) into right arm on 20 SEP 2012 and experienced some events (see case PHHY2013US000502).
Age: 85.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Decreased appetite
Clinical narrative: Case number PHHY2013US116592 is an initial spontaneous report from pharmacist via Vaccine Adverse Event Reporting System (VAERS reference number: 480806) website on 15 OCT 2013. This case refers to 85-year-old female patient. Her medical history included asthma and hypertension. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) and PNEUMOVAX (batch number: 1947AA, other manufacturer) intramuscularly in left deltoid on 24 OCT 2012. It was reported that within the next two or three days  after vaccination, on approximately 25 OCT 2012, the patient began to experience loss of appetite. No treatment was given. The reporter did not think the patient had reported this adverse experience to her health care provider. According to the reporter, the patient reported that her appetite was still poor as of 02  JAN 2013. The patient did not sought medical attention. The outcome of loss of appetite was reported as not recovered. The causality for loss of appetite was unknown for both vaccinations was unknown.
Age: 65.0
Sex: F
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: Case number PHHY2013US116543 is an initial spontaneous report received from the Vaccine Adverse Event Reporting system (VAERS, reference number: 480859) website on 15 Oct 2013. This report refers to a 65-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: unknown) on an unspecified date in 2010. On an unspecified date, two weeks after vaccination, she came down with the flu. Outcome of the event was reported as not recovered as of 30 Nov 2012. No seriousness and causality was reported for the event.
Age: 58.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US116602 is an initial spontaneous report from consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 480863) website on 15 Oct 2013. This case refers to 58-year-old female patient. Her medical history included hay fever and egg allergy. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal influenza vaccine INN) and PNEUMOVAX (batch number: not reported, other manufacturer) both on unknown dates. On an unknown date, after the vaccinations, the patient developed an allergic reaction to vaccines and was treated with a shot of adrenaline (manufacturer unknown) by a physician. She was held at the physician's office for about 8 hours for observation. The seriousness, outcome and causality of event was not reported.
Sex: U
Vaccine: FLUX
Symptoms: Dyspnoea, Hypersensitivity, Pyrexia, Rash
Clinical narrative: Case number PHHY2013US116613 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 480868) website on 15 Oct 2013. This case refers to a patient of an unknown age and gender. The patient was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN), on an unknown date. On an unspecified date, after the start of vaccination, the patient developed a severe allergic reaction which consisted of a severe rash, difficulty breathing and a high temperature. The seriousness, outcome and causality of events was not reported.
Sex: M
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: Case number PHHY2013US116614 is an initial spontaneous report from health care professional via Vaccine Adverse event Reporting System (VAERS reference number: 480870) website on 15 Oct 2013. This case refers to a male patient of an unknown age. His medical history included penicillin and streptomycin allergy. He was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN), on an unknown date. On an unspecified date, after the start of vaccination, the patient developed a rash. he stated that he had the same reaction of a rash two years in a row. The patient sought medical attention and was treated with epinephrine. The event outcome was recovered. The seriousness and causality of event was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US116623 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 480882) website on 15 OCT 2013. This case refers to a female patient of an unknown age. Her vaccination history included "quite severe" allergy to pneumonia vaccine. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal influenza vaccine INN) on an unspecified date. On an unspecified date, after the vaccination, the patient developed allergic reaction. The seriousness, outcome and causality of event were not reported.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Nausea
Clinical narrative: Case number PHHY2013US116556 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 48090) website on 15 OCT 2013. This report refers to a 47-year-old female patient. Her medical history was not reported. Concomitant medication included SYNTHROID. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) on 26 DEC 2012. ON 27 DEC 2012, she experienced extreme nausea  which lasted well into bedtime (approx 10:00 PM). Outcome of the event was reported as recovered as of 10 JAN 2013. Seriousness and causality was not reported for the event.
Sex: F
Vaccine: FLUX, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Case number PHHY2013US116644 is an initial spontaneous report received from consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 480936) web site on 15 Oct 2013. This case refers to 12 to 15 month-old female patient. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN), VARIVAX (batch number: not reported, other manufacturer) and PREVNAR (batch number: not reported, other manufacturer) on 15 Oct 2012. On 16 Oct 2012, in the evening, the patient developed a fever of 104 degrees Fahrenheit. The mother treated her with paracetamol and ibuprofen. By morning of 17 Oct 2012, the patient's temperature was 99 degrees Fahrenheit. The mother took the patient to day care on the same day. At some point during the morning, the patient developed a rash. The mother took her to the physician for treatment (treatment unspecified by the reporter). The seriousness, outcome and outcome of events was not reported.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Pain
Clinical narrative: Case number PHHY2013US116565 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 481004) website on 15 OCT 2013. This report refers to a 34-year-old female patient. Concomitant medication included multivitamins. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) on left arm on 14 DEC 2012. On the same day, post vaccination, she experienced injection painful in upper left shoulder. By evening, had pain lifting arm above shoulder or overhead. The pain has continued to date, especially painful in morning and overhead. Outcome of the events was reported as not recovered as of 11 JAN 2013. Seriousness and causality was not reported for the events.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Headache
Clinical narrative: Case number PHHY2013US116583 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481035) website on 15 OCT 2013. This case refers to 52-year-old female patient. She was vaccinated with influenza vaccine (unknown manufacturer, batch number not reported, so conservatively coded as Seasonal influenza vaccine INN) in right arm on 11 JAN 2013. On the same date, at 8:00 PM the patient had chills and severe headache lasting for 5 hours. The seriousness and causality of events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Chills, Injection site pain, Pyrexia
Clinical narrative: Case number PHHY2013US116603 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481042) on 15 OCT 2013. This report refers to a female patient of an unspecified age. Her medical history and concomitant were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) on 28 AUG 2012. On the same day, post vaccination, she experienced severe pain at the injection site and developed a fever. Her temperature went up to 104.2 F. She also experienced chills overnight. The outcome for the event was recovering. Seriousness and causality was not reported for the events.
Sex: U
Vaccine: FLUX
Symptoms: Nausea, Rash
Clinical narrative: Case number PHHY2013US116668 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481081) website on 15 OCT 2013. This case refers to a patient of an unknown age and gender. The patient's vaccination history included allergy to influenza virus vaccine. The patient was vaccinated with influenza vaccine (unknown manufacturer, batch number not reported, so conservatively coded as Seasonal Influenza vaccine INN) on an unknown date. On an unspecified date, after the vaccination, the patient developed rash and nausea. The outcome of event was reported as condition unchanged as of 30 NOV 2012. The seriousness and causality of events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Injection site rash, Myalgia
Clinical narrative: Case number PHHY2013US116609 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481122) on 15 OCT 2013. This report refers to female patient of an unspecified age. Her medical history and concomitant medications were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) on an unknown date. On an unknown date, after vaccination, she experienced myalgia and rash at the injection site. Outcome of the events was reported as recovered as of 30 NOV 2012. Seriousness and causality was not reported for the events.
Age: 66.0
Sex: F
Vaccine: FLUX, TDAP
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Case number PHHY2013US116624 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481201) on 15 OCT 2013. This report refers to a 66-year-old female patient. Her medical history and concomitant were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) and TDap (manufacturer and batch number unknown) on 08 JAN 2013. On the same day, post vaccination, she developed severe hives all over patients back and itching. Rash started to developed on chest. Took BENADRYL and by morning the rash was subsiding. NO other allergic symptoms were reported. Final outcome of the events was reported as recovered as of 14 JAN 2013. Seriousness and causality was not reported for the events.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Myalgia, Pyrexia
Clinical narrative: Case number PHHY2013US116683 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481886) on 15 OCT 2013. This report refers to a 35-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) intramuscularly on right arm on 18 JAN 2013. ON the same day, post vaccination, she experienced fever, muscle aches and pain which were treated by Motrin and heating pad. She also experienced soreness at injection site. Outcome of the events was reported as recovered as of 19 JAN 2013. Seriousness and causality was not reported for the events.
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Headache, Nausea, Pyrexia, Vomiting, Wrong drug administered
Clinical narrative: Case number PHHY2013US120739, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 485714) website on 15 Oct 2013. This report refers to an adult male patient. His medical history and concomitant medications was not reported. He does have seasonal allergies. He denied any egg, food, chemical or latex allergies. He did receive other vaccinations during his career and lifetime without difficulty. He was wrongly vaccinated with seasonal influenza vaccine (unknown manufacturer, batch number: not reported) on an unspecified date in Nov 1976. He experienced fever, nausea and vomiting (see case number: PHHY2013US116888). On an unspecified date in 1985, he experienced a 3-4 days of headache, nausea, vomiting, runny nose and congestion. He was told not to receive any influenza vaccine. It was reported that he experienced symptoms of nausea, vomiting, hot/cold chills, lower abdominal cramping, weakness and dizziness, headache, loss of appetite on 19 Oct 1980, 04 Jan 1981, 19 Dec 1984, and 15 Apr 1986. It was diagnosed as acute gastroenteritis and migraines. He also experienced chronic left Achilles tendonitis on an unspecified date in 1983. Various NSAIDs like MOTRIN, INDOCIN, TOLECTIN DS and oral prednisone and KENALOG intramuscularly. It was reported that he received the last influenza vaccine on 1985. The event outcome was completely recovered. The seriousness and causality was not reported. No additional information was available.
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Abdominal pain, Asthenia, Chills, Decreased appetite, Dizziness
Clinical narrative: Case number PHHY2013US120739, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 485714) website on 15 Oct 2013. This report refers to an adult male patient. His medical history and concomitant medications was not reported. He does have seasonal allergies. He denied any egg, food, chemical or latex allergies. He did receive other vaccinations during his career and lifetime without difficulty. He was wrongly vaccinated with seasonal influenza vaccine (unknown manufacturer, batch number: not reported) on an unspecified date in Nov 1976. He experienced fever, nausea and vomiting (see case number: PHHY2013US116888). On an unspecified date in 1985, he experienced a 3-4 days of headache, nausea, vomiting, runny nose and congestion. He was told not to receive any influenza vaccine. It was reported that he experienced symptoms of nausea, vomiting, hot/cold chills, lower abdominal cramping, weakness and dizziness, headache, loss of appetite on 19 Oct 1980, 04 Jan 1981, 19 Dec 1984, and 15 Apr 1986. It was diagnosed as acute gastroenteritis and migraines. He also experienced chronic left Achilles tendonitis on an unspecified date in 1983. Various NSAIDs like MOTRIN, INDOCIN, TOLECTIN DS and oral prednisone and KENALOG intramuscularly. It was reported that he received the last influenza vaccine on 1985. The event outcome was completely recovered. The seriousness and causality was not reported. No additional information was available.
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Feeling of body temperature change, Gastroenteritis, Headache, Migraine, Nausea
Clinical narrative: Case number PHHY2013US120739, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 485714) website on 15 Oct 2013. This report refers to an adult male patient. His medical history and concomitant medications was not reported. He does have seasonal allergies. He denied any egg, food, chemical or latex allergies. He did receive other vaccinations during his career and lifetime without difficulty. He was wrongly vaccinated with seasonal influenza vaccine (unknown manufacturer, batch number: not reported) on an unspecified date in Nov 1976. He experienced fever, nausea and vomiting (see case number: PHHY2013US116888). On an unspecified date in 1985, he experienced a 3-4 days of headache, nausea, vomiting, runny nose and congestion. He was told not to receive any influenza vaccine. It was reported that he experienced symptoms of nausea, vomiting, hot/cold chills, lower abdominal cramping, weakness and dizziness, headache, loss of appetite on 19 Oct 1980, 04 Jan 1981, 19 Dec 1984, and 15 Apr 1986. It was diagnosed as acute gastroenteritis and migraines. He also experienced chronic left Achilles tendonitis on an unspecified date in 1983. Various NSAIDs like MOTRIN, INDOCIN, TOLECTIN DS and oral prednisone and KENALOG intramuscularly. It was reported that he received the last influenza vaccine on 1985. The event outcome was completely recovered. The seriousness and causality was not reported. No additional information was available.